Cited by 672Regulation of Appetite and ObesityBariatric Surgery and OutcomesObesity, Physical Activity, Diet

Persistent metabolic adaptation 6 years after “The Biggest Loser” competition

Open access
Fothergill, Erin, Guo, Juen, Howard, Lilian, Kerns, Jennifer C., Knuth, Nicolas D., Brychta, Robert, Chen, Kong Y., Skarulis, Monica C. +3 more·2016·Obesity

Abstract

Objective: To measure long‐term changes in resting metabolic rate (RMR) and body composition in participants of “The Biggest Loser” competition. Methods: Body composition was measured by dual energy X‐ray absorptiometry, and RMR was determined by indirect calorimetry at baseline, at the end of the 30‐week competition and 6 years later. Metabolic adaptation was defined as the residual RMR after adjusting for changes in body composition and age. Results: Of the 16 “Biggest Loser” competitors originally investigated, 14 participated in this follow‐up study. Weight loss at the end of the competition was (mean ± SD) 58.3 ± 24.9 kg ( P < 0.0001), and RMR decreased by 610 ± 483 kcal/day ( P = 0.0004). After 6 years, 41.0 ± 31.3 kg of the lost weight was regained ( P = 0.0002), while RMR was 704 ± 427 kcal/day below baseline ( P < 0.0001) and metabolic adaptation was −499 ± 207 kcal/day ( P < 0.0001). Weight regain was not significantly correlated with metabolic adaptation at the competition's end ( r = − 0.1, P = 0.75), but those subjects maintaining greater weight loss at 6 years also experienced greater concurrent metabolic slowing ( r = 0.59, P = 0.025). Conclusions: Metabolic adaptation persists over time and is likely a proportional, but incomplete, response to contemporaneous efforts to reduce body weight.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.21538

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Weight loss interventions may not be sustainable and potentially lead to greater risk in the long term.

    “weight loss interventions may not be sustainable and potentially lead to greater risk in the long term [55,56,57,58,59].”

    From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [57]

    The Discussion (page unavailable in our copy) reports substantial weight regain six years after The Biggest Loser and persistent metabolic slowing, supporting concern about maintaining weight loss. But participants remained lighter on average and were relatively successful at long-term maintenance; the paper does not establish that weight-loss interventions generally lead to greater long-term risk. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The sustainability of weight loss interventions has been questioned, and weight cycling has been identified as an independent risk factor for cardiovascular disease.

    “the sustainability of weight loss interventions has been questioned [55,56,57], and weight cycling has been identified as an independent risk factor for cardiovascular disease [58,59]”
  • Adaptive thermogenesis can persist for months or years after weight loss.

    “This metabolic adaptation can persist for months or years after weight loss”

    From Weight maintenance after discontinuation of GLP-1 therapies (2026) · cites this paper as [41]

  • Semaglutide and tirzepatide act in the central nervous system to reduce food intake and body weight.

    “Semaglutide (approved in 2021 for chronic weight management) and tirzepatide (approved in 2023 for chronic weight management) are AOMs that act in the central nervous system to reduce food intake and body weight [19].”

    From Nutritional considerations with antiobesity medications (2024) · cites this paper as [19]

    The Methods describe a six-year follow-up of Biggest Loser participants, and the Discussion addresses resting metabolic rate, hunger, and weight regain. Neither those passages nor searches for semaglutide, tirzepatide, central nervous system action, and anti-obesity medications found support for the attributed drug mechanism. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • The magnitude of metabolic adaptation did not show a clear association with the amount of weight regained, suggesting that reductions in energy expenditure may occur independently of long-term weight changes in some individuals.

    “The magnitude of metabolic adaptation did not show a clear association with the amount of weight regained, suggesting that reductions in energy expenditure may occur independently of long-term weight changes in some individuals [63].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fothergill, E., Guo, J., Howard, L., Kerns, J. C., Knuth, N. D., Brychta, R., Chen, K. Y., Skarulis, M. C., Walter, M., Walter, P. J., & Hall, K. D.
Affiliations
  • National Institutes of Health (US)
  • Washington DC VA Medical Center (US)
  • Towson University (US)
Corresponding author
Hall, Kevin D.
Venue
Obesity
Publisher
Wiley
Published
2016-05-02
Volume
24
Issue
8
Pages
1612-1619
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W2346401028
Cited by
672
References
41
Citations by year
2026: 52 · 2025: 64 · 2024: 51 · 2023: 56 · 2022: 64 · 2021: 79 · 2020: 76 · 2019: 59 · 2018: 78 · 2017: 61 · 2016: 31 · 2014: 1
FWCI
48.56
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
metabolic adaptation, resting metabolic rate, weight loss, weight regain, body composition, The Biggest Loser, long-term follow-up, energy expenditure
MeSH terms
Adult, Basal Metabolism, Body Composition, Body Weight, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Morbid, Weight Loss, Absorptiometry, Photon, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review